These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9750919)

  • 1. Botulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients.
    Cullis PA; O'Brien CF; Truong DD; Koller M; Villegas TP; Wallace JD
    Adv Neurol; 1998; 78():227-30. PubMed ID: 9750919
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin in cervical dystonia.
    Tsui JK; Calne DB
    Adv Neurol; 1988; 49():473-8. PubMed ID: 3344637
    [No Abstract]   [Full Text] [Related]  

  • 3. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.
    Comella CL; Jankovic J; Shannon KM; Tsui J; Swenson M; Leurgans S; Fan W;
    Neurology; 2005 Nov; 65(9):1423-9. PubMed ID: 16275831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of botulinum toxin in the treatment of cervical dystonia.
    Poewe W; Wissel J
    Baillieres Clin Neurol; 1993 Apr; 2(1):179-85. PubMed ID: 8143072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
    Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C; Swenson MR; Tarsy D; Murray JJ; Koller M; Wallace JD
    Neurology; 1997 Sep; 49(3):701-7. PubMed ID: 9305326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical dystonia: a review the role of botulinum toxin.
    Edwards LL; Normand MM; Wszolek ZK
    Nebr Med J; 1995 May; 80(5):109-15. PubMed ID: 7791942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cervical dystonia (torticollis) in adults with botulinum A toxin.
    Metzer WS; Jenkins T
    J Ark Med Soc; 1992 Aug; 89(3):133-4. PubMed ID: 1517180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dystonia as the cause of pharyngolaryngeal motility disorders].
    Zwirner P; Dressler D
    HNO; 1995 Aug; 43(8):498-501. PubMed ID: 7558908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
    Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
    Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
    [No Abstract]   [Full Text] [Related]  

  • 11. No effects on heart-rate variability and cardiovascular reflex tests after botulinum toxin treatment of cervical dystonia.
    Nebe A; Schelosky L; Wissel J; Ebersbach G; Scholz U; Poewe W
    Mov Disord; 1996 May; 11(3):337-9. PubMed ID: 8723158
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin assessment, intervention and aftercare for cervical dystonia and other causes of hypertonia of the neck: international consensus statement.
    Novak I; Campbell L; Boyce M; Fung VS;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():94-108. PubMed ID: 20633181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia.
    Kojovic M; Caronni A; Bologna M; Rothwell JC; Bhatia KP; Edwards MJ
    Mov Disord; 2011 Jun; 26(7):1282-9. PubMed ID: 21469207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of distant effects of local injections of botulinum toxin.
    Garner CG; Straube A; Witt TN; Gasser T; Oertel WH
    Mov Disord; 1993; 8(1):33-7. PubMed ID: 8380486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia.
    Lu CS; Chen RS; Tsai CH
    J Formos Med Assoc; 1995 Apr; 94(4):189-92. PubMed ID: 7606182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials.
    Lew MF; Brashear A; Factor S
    Neurology; 2000; 55(12 Suppl 5):S29-35. PubMed ID: 11188982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
    Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
    Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin.
    Dykstra D; Ellingham C; Belfie A; Baxter T; Lee M; Voelker A
    Mov Disord; 1993; 8(1):38-42. PubMed ID: 8419806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.